Novel Adaptive T-Cell Oncological Treatments Lead to New Challenges for Medical Emergency Teams: A 2-Year Experience From a Tertiary-Care Hospital in Switzerland
Enregistré dans:
Auteurs principaux: | Anna Sarah Messmer, MD, Yok-Ai Que, MD, PhD, Christoph Schankin, MD, PhD, Yara Banz, MD, PhD, Ulrike Bacher, MD, Urban Novak, MD, Thomas Pabst, MD |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Wolters Kluwer
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/5d783eb858b94f3db43a5113857ec6df |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Fewer Intubations but Higher Mortality Among Intubated Coronavirus Disease 2019 Patients During the Second Than the First Wave
par: Christina Routsi, MD, PhD, et autres
Publié: (2021) -
Identification of Aggravation-Predicting Gene Polymorphisms in Coronavirus Disease 2019 Patients Using a Candidate Gene Approach Associated With Multiple Phase Pathogenesis: A Study in a Japanese City of 1 Million People
par: Naoki Tanimine, MD, PhD, et autres
Publié: (2021) -
Detectable A Disintegrin and Metalloproteinase With Thrombospondin Motifs-1 in Serum Is Associated With Adverse Outcome in Pediatric Sepsis
par: Navin P. Boeddha, MD, PhD, et autres
Publié: (2021) -
Paving the Road for the Adoption of Normothermic Regional Perfusion in Canada
par: John Basmaji, MD, et autres
Publié: (2021) -
Effect of Inhaled Xenon on Cardiac Function in Comatose Survivors of Out-of-Hospital Cardiac Arrest—A Substudy of the Xenon in Combination With Hypothermia After Cardiac Arrest Trial
par: Antti Saraste, MD, PhD, et autres
Publié: (2021)